Benzinga | May 6, 2021 09:04AM EDT

Albireo Pharma Q1 EPS $(2.29) Misses $(1.77) Estimate, Sales $2.00M Miss $2.13M Estimate

Albireo Pharma (NASDAQ:ALBO) reported quarterly losses of $(2.29) per share which missed the analyst consensus estimate of $(1.77) by 29.38 percent. This is a 2.69 percent decrease over losses of $(2.23) per share from the same period last year. The company reported quarterly sales of $2.00 million which missed the analyst consensus estimate of $2.13 million by 6.10 percent. This is a 29.12 percent increase over sales of $1.55 million the same period last year.